New Roadmap Offers Path To Finding Better Ways To Prescribe Antibiotics In Effort To Help Address Resistance

Nature: Progress on antibiotic resistance
Editorial Board

“…Speeding up [the process of ensuring a patient who is ill receives effective treatment] will require major advances in what microbiologists call antimicrobial susceptibility testing. … Advances in genomics mean that rapid DNA sequencing can identify bacteria within hours. It can also quickly and accurately detect antibiotic resistance and susceptibility for tuberculosis. Developed further, this and other technologies could deliver results within an hour of a sample being taken from a patient. That would be a game-changer — but it has not yet happened. Why? Talk to the people involved — physicians, researchers, testing labs, regulators, and commercial firms among them — and all will offer their own reasons. One result of such discussion is published this week — a consensus statement that seeks to find common ground on defining the obstacles and recommending ways to overcome them. … Policymakers repeatedly say that action is needed on antibiotic resistance. The community has responded with a way forward” (10/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.